Global Radioimmunotherapy Market Insights and Forecast to 2031

Report ID: 1564404 | Published Date: Sep 2024 | No. of Page: 105 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Radioimmunotherapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Non Hodgkin Lymphoma (NHL)
        1.2.3 Follicular Lymphoma
        1.2.4 Solid Tumors
        1.2.5 Breast Cancer
        1.2.6 Ovarian Cancer
        1.2.7 Osteosarcoma
        1.2.8 Neuroblastoma
        1.2.9 Prostate Cancer
    1.3 Market by Application
        1.3.1 Global Radioimmunotherapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Tumor Antigens
        1.3.3 Radionuclides
        1.3.4 Antibodies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Radioimmunotherapy Market Perspective (2017-2028)
    2.2 Radioimmunotherapy Growth Trends by Region
        2.2.1 Radioimmunotherapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Radioimmunotherapy Historic Market Size by Region (2017-2022)
        2.2.3 Radioimmunotherapy Forecasted Market Size by Region (2023-2028)
    2.3 Radioimmunotherapy Market Dynamics
        2.3.1 Radioimmunotherapy Industry Trends
        2.3.2 Radioimmunotherapy Market Drivers
        2.3.3 Radioimmunotherapy Market Challenges
        2.3.4 Radioimmunotherapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Radioimmunotherapy Players by Revenue
        3.1.1 Global Top Radioimmunotherapy Players by Revenue (2017-2022)
        3.1.2 Global Radioimmunotherapy Revenue Market Share by Players (2017-2022)
    3.2 Global Radioimmunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Radioimmunotherapy Revenue
    3.4 Global Radioimmunotherapy Market Concentration Ratio
        3.4.1 Global Radioimmunotherapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Radioimmunotherapy Revenue in 2021
    3.5 Radioimmunotherapy Key Players Head office and Area Served
    3.6 Key Players Radioimmunotherapy Product Solution and Service
    3.7 Date of Enter into Radioimmunotherapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Radioimmunotherapy Breakdown Data by Type
    4.1 Global Radioimmunotherapy Historic Market Size by Type (2017-2022)
    4.2 Global Radioimmunotherapy Forecasted Market Size by Type (2023-2028)
5 Radioimmunotherapy Breakdown Data by Application
    5.1 Global Radioimmunotherapy Historic Market Size by Application (2017-2022)
    5.2 Global Radioimmunotherapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Radioimmunotherapy Market Size (2017-2028)
    6.2 North America Radioimmunotherapy Market Size by Type
        6.2.1 North America Radioimmunotherapy Market Size by Type (2017-2022)
        6.2.2 North America Radioimmunotherapy Market Size by Type (2023-2028)
        6.2.3 North America Radioimmunotherapy Market Share by Type (2017-2028)
    6.3 North America Radioimmunotherapy Market Size by Application
        6.3.1 North America Radioimmunotherapy Market Size by Application (2017-2022)
        6.3.2 North America Radioimmunotherapy Market Size by Application (2023-2028)
        6.3.3 North America Radioimmunotherapy Market Share by Application (2017-2028)
    6.4 North America Radioimmunotherapy Market Size by Country
        6.4.1 North America Radioimmunotherapy Market Size by Country (2017-2022)
        6.4.2 North America Radioimmunotherapy Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Radioimmunotherapy Market Size (2017-2028)
    7.2 Europe Radioimmunotherapy Market Size by Type
        7.2.1 Europe Radioimmunotherapy Market Size by Type (2017-2022)
        7.2.2 Europe Radioimmunotherapy Market Size by Type (2023-2028)
        7.2.3 Europe Radioimmunotherapy Market Share by Type (2017-2028)
    7.3 Europe Radioimmunotherapy Market Size by Application
        7.3.1 Europe Radioimmunotherapy Market Size by Application (2017-2022)
        7.3.2 Europe Radioimmunotherapy Market Size by Application (2023-2028)
        7.3.3 Europe Radioimmunotherapy Market Share by Application (2017-2028)
    7.4 Europe Radioimmunotherapy Market Size by Country
        7.4.1 Europe Radioimmunotherapy Market Size by Country (2017-2022)
        7.4.2 Europe Radioimmunotherapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Radioimmunotherapy Market Size (2017-2028)
    8.2 Asia-Pacific Radioimmunotherapy Market Size by Type
        8.2.1 Asia-Pacific Radioimmunotherapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Radioimmunotherapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Radioimmunotherapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Radioimmunotherapy Market Size by Application
        8.3.1 Asia-Pacific Radioimmunotherapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Radioimmunotherapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Radioimmunotherapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Radioimmunotherapy Market Size by Region
        8.4.1 Asia-Pacific Radioimmunotherapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Radioimmunotherapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Radioimmunotherapy Market Size (2017-2028)
    9.2 Latin America Radioimmunotherapy Market Size by Type
        9.2.1 Latin America Radioimmunotherapy Market Size by Type (2017-2022)
        9.2.2 Latin America Radioimmunotherapy Market Size by Type (2023-2028)
        9.2.3 Latin America Radioimmunotherapy Market Share by Type (2017-2028)
    9.3 Latin America Radioimmunotherapy Market Size by Application
        9.3.1 Latin America Radioimmunotherapy Market Size by Application (2017-2022)
        9.3.2 Latin America Radioimmunotherapy Market Size by Application (2023-2028)
        9.3.3 Latin America Radioimmunotherapy Market Share by Application (2017-2028)
    9.4 Latin America Radioimmunotherapy Market Size by Country
        9.4.1 Latin America Radioimmunotherapy Market Size by Country (2017-2022)
        9.4.2 Latin America Radioimmunotherapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Radioimmunotherapy Market Size (2017-2028)
    10.2 Middle East & Africa Radioimmunotherapy Market Size by Type
        10.2.1 Middle East & Africa Radioimmunotherapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Radioimmunotherapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Radioimmunotherapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Radioimmunotherapy Market Size by Application
        10.3.1 Middle East & Africa Radioimmunotherapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Radioimmunotherapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Radioimmunotherapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Radioimmunotherapy Market Size by Country
        10.4.1 Middle East & Africa Radioimmunotherapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Radioimmunotherapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Bayer Healthcare Pharmaceuticals
        11.1.1 Bayer Healthcare Pharmaceuticals Company Details
        11.1.2 Bayer Healthcare Pharmaceuticals Business Overview
        11.1.3 Bayer Healthcare Pharmaceuticals Radioimmunotherapy Introduction
        11.1.4 Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
        11.1.5 Bayer Healthcare Pharmaceuticals Recent Developments
    11.2 BioSynthema
        11.2.1 BioSynthema Company Details
        11.2.2 BioSynthema Business Overview
        11.2.3 BioSynthema Radioimmunotherapy Introduction
        11.2.4 BioSynthema Revenue in Radioimmunotherapy Business (2017-2022)
        11.2.5 BioSynthema Recent Developments
    11.3 Clarity Pharmaceuticals
        11.3.1 Clarity Pharmaceuticals Company Details
        11.3.2 Clarity Pharmaceuticals Business Overview
        11.3.3 Clarity Pharmaceuticals Radioimmunotherapy Introduction
        11.3.4 Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
        11.3.5 Clarity Pharmaceuticals Recent Developments
    11.4 Curasight
        11.4.1 Curasight Company Details
        11.4.2 Curasight Business Overview
        11.4.3 Curasight Radioimmunotherapy Introduction
        11.4.4 Curasight Revenue in Radioimmunotherapy Business (2017-2022)
        11.4.5 Curasight Recent Developments
    11.5 Endocyte
        11.5.1 Endocyte Company Details
        11.5.2 Endocyte Business Overview
        11.5.3 Endocyte Radioimmunotherapy Introduction
        11.5.4 Endocyte Revenue in Radioimmunotherapy Business (2017-2022)
        11.5.5 Endocyte Recent Developments
    11.6 Immunomedics
        11.6.1 Immunomedics Company Details
        11.6.2 Immunomedics Business Overview
        11.6.3 Immunomedics Radioimmunotherapy Introduction
        11.6.4 Immunomedics Revenue in Radioimmunotherapy Business (2017-2022)
        11.6.5 Immunomedics Recent Developments
    11.7 Molecular Insight Pharmaceuticals
        11.7.1 Molecular Insight Pharmaceuticals Company Details
        11.7.2 Molecular Insight Pharmaceuticals Business Overview
        11.7.3 Molecular Insight Pharmaceuticals Radioimmunotherapy Introduction
        11.7.4 Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
        11.7.5 Molecular Insight Pharmaceuticals Recent Developments
    11.8 Nordic Nanovector
        11.8.1 Nordic Nanovector Company Details
        11.8.2 Nordic Nanovector Business Overview
        11.8.3 Nordic Nanovector Radioimmunotherapy Introduction
        11.8.4 Nordic Nanovector Revenue in Radioimmunotherapy Business (2017-2022)
        11.8.5 Nordic Nanovector Recent Developments
    11.9 PDL Biopharma
        11.9.1 PDL Biopharma Company Details
        11.9.2 PDL Biopharma Business Overview
        11.9.3 PDL Biopharma Radioimmunotherapy Introduction
        11.9.4 PDL Biopharma Revenue in Radioimmunotherapy Business (2017-2022)
        11.9.5 PDL Biopharma Recent Developments
    11.10 Philogen
        11.10.1 Philogen Company Details
        11.10.2 Philogen Business Overview
        11.10.3 Philogen Radioimmunotherapy Introduction
        11.10.4 Philogen Revenue in Radioimmunotherapy Business (2017-2022)
        11.10.5 Philogen Recent Developments
    11.11 RadioMedix
        11.11.1 RadioMedix Company Details
        11.11.2 RadioMedix Business Overview
        11.11.3 RadioMedix Radioimmunotherapy Introduction
        11.11.4 RadioMedix Revenue in Radioimmunotherapy Business (2017-2022)
        11.11.5 RadioMedix Recent Developments
    11.12 Stella Pharma
        11.12.1 Stella Pharma Company Details
        11.12.2 Stella Pharma Business Overview
        11.12.3 Stella Pharma Radioimmunotherapy Introduction
        11.12.4 Stella Pharma Revenue in Radioimmunotherapy Business (2017-2022)
        11.12.5 Stella Pharma Recent Developments
    11.13 Telix Pharmaceuticals
        11.13.1 Telix Pharmaceuticals Company Details
        11.13.2 Telix Pharmaceuticals Business Overview
        11.13.3 Telix Pharmaceuticals Radioimmunotherapy Introduction
        11.13.4 Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022)
        11.13.5 Telix Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Radioimmunotherapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Non Hodgkin Lymphoma (NHL)
    Table 3. Key Players of Follicular Lymphoma
    Table 4. Key Players of Solid Tumors
    Table 5. Key Players of Breast Cancer
    Table 6. Key Players of Ovarian Cancer
    Table 7. Key Players of Osteosarcoma
    Table 8. Key Players of Neuroblastoma
    Table 9. Key Players of Prostate Cancer
    Table 10. Global Radioimmunotherapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 11. Global Radioimmunotherapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 12. Global Radioimmunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 13. Global Radioimmunotherapy Market Share by Region (2017-2022)
    Table 14. Global Radioimmunotherapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 15. Global Radioimmunotherapy Market Share by Region (2023-2028)
    Table 16. Radioimmunotherapy Market Trends
    Table 17. Radioimmunotherapy Market Drivers
    Table 18. Radioimmunotherapy Market Challenges
    Table 19. Radioimmunotherapy Market Restraints
    Table 20. Global Radioimmunotherapy Revenue by Players (2017-2022) & (US$ Million)
    Table 21. Global Radioimmunotherapy Revenue Share by Players (2017-2022)
    Table 22. Global Top Radioimmunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2021)
    Table 23. Ranking of Global Top Radioimmunotherapy Companies by Revenue (US$ Million) in 2021
    Table 24. Global 5 Largest Players Market Share by Radioimmunotherapy Revenue (CR5 and HHI) & (2017-2022)
    Table 25. Key Players Headquarters and Area Served
    Table 26. Key Players Radioimmunotherapy Product Solution and Service
    Table 27. Date of Enter into Radioimmunotherapy Market
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 30. Global Radioimmunotherapy Revenue Market Share by Type (2017-2022)
    Table 31. Global Radioimmunotherapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 32. Global Radioimmunotherapy Revenue Market Share by Type (2023-2028)
    Table 33. Global Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 34. Global Radioimmunotherapy Revenue Share by Application (2017-2022)
    Table 35. Global Radioimmunotherapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 36. Global Radioimmunotherapy Revenue Share by Application (2023-2028)
    Table 37. North America Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 38. North America Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 39. North America Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 40. North America Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 41. North America Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 42. North America Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Europe Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Europe Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Europe Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Europe Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Europe Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 48. Europe Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Asia Pacific Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Asia Pacific Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Asia Pacific Radioimmunotherapy Market Size by Region (2017-2022) & (US$ Million)
    Table 54. Asia Pacific Radioimmunotherapy Market Size by Region (2023-2028) & (US$ Million)
    Table 55. Latin America Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Latin America Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Latin America Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Latin America Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Latin America Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Latin America Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Radioimmunotherapy Market Size by Type (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Radioimmunotherapy Market Size by Type (2023-2028) & (US$ Million)
    Table 63. Middle East and Africa Radioimmunotherapy Market Size by Application (2017-2022) & (US$ Million)
    Table 64. Middle East and Africa Radioimmunotherapy Market Size by Application (2023-2028) & (US$ Million)
    Table 65. Middle East and Africa Radioimmunotherapy Market Size by Country (2017-2022) & (US$ Million)
    Table 66. Middle East and Africa Radioimmunotherapy Market Size by Country (2023-2028) & (US$ Million)
    Table 67. Bayer Healthcare Pharmaceuticals Company Details
    Table 68. Bayer Healthcare Pharmaceuticals Business Overview
    Table 69. Bayer Healthcare Pharmaceuticals Radioimmunotherapy Product
    Table 70. Bayer Healthcare Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 71. Bayer Healthcare Pharmaceuticals Recent Developments
    Table 72. BioSynthema Company Details
    Table 73. BioSynthema Business Overview
    Table 74. BioSynthema Radioimmunotherapy Product
    Table 75. BioSynthema Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 76. BioSynthema Recent Developments
    Table 77. Clarity Pharmaceuticals Company Details
    Table 78. Clarity Pharmaceuticals Business Overview
    Table 79. Clarity Pharmaceuticals Radioimmunotherapy Product
    Table 80. Clarity Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 81. Clarity Pharmaceuticals Recent Developments
    Table 82. Curasight Company Details
    Table 83. Curasight Business Overview
    Table 84. Curasight Radioimmunotherapy Product
    Table 85. Curasight Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 86. Curasight Recent Developments
    Table 87. Endocyte Company Details
    Table 88. Endocyte Business Overview
    Table 89. Endocyte Radioimmunotherapy Product
    Table 90. Endocyte Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 91. Endocyte Recent Developments
    Table 92. Immunomedics Company Details
    Table 93. Immunomedics Business Overview
    Table 94. Immunomedics Radioimmunotherapy Product
    Table 95. Immunomedics Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 96. Immunomedics Recent Developments
    Table 97. Molecular Insight Pharmaceuticals Company Details
    Table 98. Molecular Insight Pharmaceuticals Business Overview
    Table 99. Molecular Insight Pharmaceuticals Radioimmunotherapy Product
    Table 100. Molecular Insight Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 101. Molecular Insight Pharmaceuticals Recent Developments
    Table 102. Nordic Nanovector Company Details
    Table 103. Nordic Nanovector Business Overview
    Table 104. Nordic Nanovector Radioimmunotherapy Product
    Table 105. Nordic Nanovector Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 106. Nordic Nanovector Recent Developments
    Table 107. PDL Biopharma Company Details
    Table 108. PDL Biopharma Business Overview
    Table 109. PDL Biopharma Radioimmunotherapy Product
    Table 110. PDL Biopharma Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 111. PDL Biopharma Recent Developments
    Table 112. Philogen Company Details
    Table 113. Philogen Business Overview
    Table 114. Philogen Radioimmunotherapy Product
    Table 115. Philogen Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 116. Philogen Recent Developments
    Table 117. RadioMedix Company Details
    Table 118. RadioMedix Business Overview
    Table 119. RadioMedix Radioimmunotherapy Product
    Table 120. RadioMedix Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 121. RadioMedix Recent Developments
    Table 122. Stella Pharma Company Details
    Table 123. Stella Pharma Business Overview
    Table 124. Stella Pharma Radioimmunotherapy Product
    Table 125. Stella Pharma Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 126. Stella Pharma Recent Developments
    Table 127. Telix Pharmaceuticals Company Details
    Table 128. Telix Pharmaceuticals Business Overview
    Table 129. Telix Pharmaceuticals Radioimmunotherapy Product
    Table 130. Telix Pharmaceuticals Revenue in Radioimmunotherapy Business (2017-2022) & (US$ Million)
    Table 131. Telix Pharmaceuticals Recent Developments
    Table 132. Research Programs/Design for This Report
    Table 133. Key Data Information from Secondary Sources
    Table 134. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Radioimmunotherapy Market Share by Type: 2021 VS 2028
    Figure 2. Non Hodgkin Lymphoma (NHL) Features
    Figure 3. Follicular Lymphoma Features
    Figure 4. Solid Tumors Features
    Figure 5. Breast Cancer Features
    Figure 6. Ovarian Cancer Features
    Figure 7. Osteosarcoma Features
    Figure 8. Neuroblastoma Features
    Figure 9. Prostate Cancer Features
    Figure 10. Global Radioimmunotherapy Market Share by Application: 2021 VS 2028
    Figure 11. Tumor Antigens Case Studies
    Figure 12. Radionuclides Case Studies
    Figure 13. Antibodies Case Studies
    Figure 14. Radioimmunotherapy Report Years Considered
    Figure 15. Global Radioimmunotherapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global Radioimmunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Radioimmunotherapy Market Share by Region: 2021 VS 2028
    Figure 18. Global Radioimmunotherapy Market Share by Players in 2021
    Figure 19. Global Top Radioimmunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radioimmunotherapy as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by Radioimmunotherapy Revenue in 2021
    Figure 21. North America Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America Radioimmunotherapy Market Size Market Share by Type (2017-2028)
    Figure 23. North America Radioimmunotherapy Market Size Market Share by Application (2017-2028)
    Figure 24. North America Radioimmunotherapy Market Size Share by Country (2017-2028)
    Figure 25. United States Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe Radioimmunotherapy Market Size Market Share by Type (2017-2028)
    Figure 29. Europe Radioimmunotherapy Market Size Market Share by Application (2017-2028)
    Figure 30. Europe Radioimmunotherapy Market Size Share by Country (2017-2028)
    Figure 31. Germany Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific Radioimmunotherapy Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific Radioimmunotherapy Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific Radioimmunotherapy Market Size Share by Region (2017-2028)
    Figure 41. China Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America Radioimmunotherapy Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America Radioimmunotherapy Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America Radioimmunotherapy Market Size Share by Country (2017-2028)
    Figure 51. Mexico Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Radioimmunotherapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa Radioimmunotherapy Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa Radioimmunotherapy Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa Radioimmunotherapy Market Size Share by Country (2017-2028)
    Figure 57. Turkey Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE Radioimmunotherapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 61. BioSynthema Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 62. Clarity Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 63. Curasight Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 64. Endocyte Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 65. Immunomedics Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 66. Molecular Insight Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 67. Nordic Nanovector Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 68. PDL Biopharma Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 69. Philogen Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 70. RadioMedix Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 71. Stella Pharma Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 72. Telix Pharmaceuticals Revenue Growth Rate in Radioimmunotherapy Business (2017-2022)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer Healthcare Pharmaceuticals
BioSynthema
Clarity Pharmaceuticals
Curasight
Endocyte
Immunomedics
Molecular Insight Pharmaceuticals
Nordic Nanovector
PDL Biopharma
Philogen
RadioMedix
Stella Pharma
Telix Pharmaceuticals
Frequently Asked Questions
Radioimmunotherapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Radioimmunotherapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Radioimmunotherapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Proto-Oncogene Drgu

Proto-Oncogene Drgu market is segmented by Type and by Application. Players, stakeholders, and ot ... Read More